Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
STAT5A
|
ENSG00000126561.12 | signal transducer and activator of transcription 5A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT5A | hg19_v2_chr17_+_40440481_40440561 | 0.02 | 9.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_50649192 | 5.72 |
ENST00000443053.2
ENST00000348721.3 |
CISH
|
cytokine inducible SH2-containing protein |
chr1_-_36937075 | 5.46 |
ENST00000464465.2
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr12_-_15082050 | 5.14 |
ENST00000540097.1
|
ERP27
|
endoplasmic reticulum protein 27 |
chr3_+_111260954 | 5.05 |
ENST00000283285.5
|
CD96
|
CD96 molecule |
chr4_+_155484103 | 4.79 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr4_-_155511887 | 4.61 |
ENST00000302053.3
ENST00000403106.3 |
FGA
|
fibrinogen alpha chain |
chr2_+_90198535 | 4.57 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr2_-_89292422 | 4.50 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr17_-_33864772 | 4.46 |
ENST00000361112.4
|
SLFN12L
|
schlafen family member 12-like |
chr1_-_36948879 | 4.35 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr3_+_111260980 | 4.16 |
ENST00000438817.2
|
CD96
|
CD96 molecule |
chr14_+_22320634 | 3.94 |
ENST00000390435.1
|
TRAV8-3
|
T cell receptor alpha variable 8-3 |
chr10_-_6104253 | 3.84 |
ENST00000256876.6
ENST00000379954.1 ENST00000379959.3 |
IL2RA
|
interleukin 2 receptor, alpha |
chr1_-_162381907 | 3.83 |
ENST00000367929.2
ENST00000359567.3 |
SH2D1B
|
SH2 domain containing 1B |
chrX_+_78426469 | 3.78 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
chr15_+_58430567 | 3.75 |
ENST00000536493.1
|
AQP9
|
aquaporin 9 |
chr2_-_89399845 | 3.71 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr2_-_89160770 | 3.66 |
ENST00000390240.2
|
IGKJ3
|
immunoglobulin kappa joining 3 |
chr12_+_10705960 | 3.62 |
ENST00000544591.1
|
RP11-291B21.2
|
RP11-291B21.2 |
chr7_+_142008340 | 3.62 |
ENST00000390387.3
|
TRBV3-1
|
T cell receptor beta variable 3-1 |
chr4_+_155484155 | 3.61 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
chr12_-_10151773 | 3.59 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
chr7_-_142198049 | 3.58 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
chr1_-_159046617 | 3.57 |
ENST00000368130.4
|
AIM2
|
absent in melanoma 2 |
chr4_+_40194570 | 3.57 |
ENST00000507851.1
|
RHOH
|
ras homolog family member H |
chr19_+_47835404 | 3.49 |
ENST00000595464.1
|
C5AR2
|
complement component 5a receptor 2 |
chr6_+_131894284 | 3.39 |
ENST00000368087.3
ENST00000356962.2 |
ARG1
|
arginase 1 |
chr7_-_36634181 | 3.38 |
ENST00000538464.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr19_+_52264104 | 3.33 |
ENST00000340023.6
|
FPR2
|
formyl peptide receptor 2 |
chr9_-_97402531 | 3.29 |
ENST00000415431.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
chr14_+_22111077 | 3.19 |
ENST00000390423.2
|
TRAV1-2
|
T cell receptor alpha variable 1-2 |
chr2_-_75796837 | 3.18 |
ENST00000233712.1
|
EVA1A
|
eva-1 homolog A (C. elegans) |
chr4_-_71532207 | 3.16 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr9_-_97402413 | 3.11 |
ENST00000414122.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
chr8_-_134114721 | 3.06 |
ENST00000522119.1
ENST00000523610.1 ENST00000521302.1 ENST00000519558.1 ENST00000519747.1 ENST00000517648.1 |
SLA
|
Src-like-adaptor |
chr4_-_71532601 | 3.03 |
ENST00000510614.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr3_+_111260856 | 3.02 |
ENST00000352690.4
|
CD96
|
CD96 molecule |
chr14_+_22180536 | 3.02 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
chr1_+_158901329 | 3.00 |
ENST00000368140.1
ENST00000368138.3 ENST00000392254.2 ENST00000392252.3 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr4_-_71532339 | 3.00 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr7_-_139727118 | 2.98 |
ENST00000484111.1
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr4_-_71532668 | 2.97 |
ENST00000510437.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr8_-_6836156 | 2.97 |
ENST00000382679.2
|
DEFA1
|
defensin, alpha 1 |
chr11_-_111320706 | 2.97 |
ENST00000531398.1
|
POU2AF1
|
POU class 2 associating factor 1 |
chr3_+_50649302 | 2.96 |
ENST00000446044.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
chr16_+_27413483 | 2.95 |
ENST00000337929.3
ENST00000564089.1 |
IL21R
|
interleukin 21 receptor |
chr12_+_66696322 | 2.93 |
ENST00000247815.4
|
HELB
|
helicase (DNA) B |
chr18_-_67624160 | 2.90 |
ENST00000581982.1
ENST00000280200.4 |
CD226
|
CD226 molecule |
chr19_+_55361898 | 2.83 |
ENST00000326321.3
ENST00000270442.5 |
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 |
chr19_+_18284477 | 2.83 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr1_+_159770292 | 2.81 |
ENST00000536257.1
ENST00000321935.6 |
FCRL6
|
Fc receptor-like 6 |
chr8_-_134114866 | 2.81 |
ENST00000524345.1
|
SLA
|
Src-like-adaptor |
chr2_+_7865923 | 2.80 |
ENST00000417930.1
|
AC092580.4
|
AC092580.4 |
chr2_-_89161432 | 2.79 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
chr22_-_42828375 | 2.76 |
ENST00000329021.5
|
NFAM1
|
NFAT activating protein with ITAM motif 1 |
chr3_-_120365866 | 2.74 |
ENST00000475447.2
|
HGD
|
homogentisate 1,2-dioxygenase |
chr19_-_51875894 | 2.73 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr17_-_34207295 | 2.72 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr1_-_161600822 | 2.69 |
ENST00000534776.1
ENST00000540048.1 |
FCGR3B
FCGR3A
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr14_-_25103472 | 2.69 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr17_-_64216748 | 2.63 |
ENST00000585162.1
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr4_-_38858428 | 2.63 |
ENST00000436693.2
ENST00000508254.1 ENST00000514655.1 ENST00000506146.1 |
TLR6
TLR1
|
toll-like receptor 6 toll-like receptor 1 |
chr2_+_218989991 | 2.62 |
ENST00000453237.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
chr2_+_90139056 | 2.61 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr18_-_67623906 | 2.61 |
ENST00000583955.1
|
CD226
|
CD226 molecule |
chr14_+_23009190 | 2.59 |
ENST00000390532.1
|
TRAJ5
|
T cell receptor alpha joining 5 |
chr5_-_138725594 | 2.54 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chr8_-_134114887 | 2.54 |
ENST00000519341.1
|
SLA
|
Src-like-adaptor |
chr1_+_158801095 | 2.53 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr12_-_54689532 | 2.51 |
ENST00000540264.2
ENST00000312156.4 |
NFE2
|
nuclear factor, erythroid 2 |
chr19_-_10446449 | 2.50 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr16_+_30485267 | 2.50 |
ENST00000569725.1
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr14_+_22458631 | 2.50 |
ENST00000390444.1
|
TRAV16
|
T cell receptor alpha variable 16 |
chr14_-_25103388 | 2.47 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr5_-_138725560 | 2.44 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr11_-_104893863 | 2.43 |
ENST00000260315.3
ENST00000526056.1 ENST00000531367.1 ENST00000456094.1 ENST00000444749.2 ENST00000393141.2 ENST00000418434.1 ENST00000393139.2 |
CASP5
|
caspase 5, apoptosis-related cysteine peptidase |
chr14_+_22204418 | 2.41 |
ENST00000390426.2
|
TRAV4
|
T cell receptor alpha variable 4 |
chr2_+_163200848 | 2.40 |
ENST00000233612.4
|
GCA
|
grancalcin, EF-hand calcium binding protein |
chr2_-_89340242 | 2.37 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr7_-_142224280 | 2.37 |
ENST00000390367.3
|
TRBV11-1
|
T cell receptor beta variable 11-1 |
chr7_+_150382781 | 2.34 |
ENST00000223293.5
ENST00000474605.1 |
GIMAP2
|
GTPase, IMAP family member 2 |
chr2_-_89160117 | 2.34 |
ENST00000390238.2
|
IGKJ5
|
immunoglobulin kappa joining 5 |
chr6_-_31560729 | 2.33 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
chr3_-_172019686 | 2.32 |
ENST00000596321.1
|
AC092964.2
|
Uncharacterized protein |
chr1_+_111415757 | 2.32 |
ENST00000429072.2
ENST00000271324.5 |
CD53
|
CD53 molecule |
chr12_+_8666126 | 2.32 |
ENST00000299665.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
chr12_-_15103621 | 2.31 |
ENST00000536592.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr1_-_161600990 | 2.29 |
ENST00000531221.1
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr1_-_161600942 | 2.29 |
ENST00000421702.2
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr15_-_38856836 | 2.29 |
ENST00000450598.2
ENST00000559830.1 ENST00000558164.1 ENST00000310803.5 |
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
chr6_-_154567984 | 2.28 |
ENST00000517438.1
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
chrY_+_15016725 | 2.28 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr3_+_81043000 | 2.27 |
ENST00000482617.1
|
RP11-6B4.1
|
RP11-6B4.1 |
chr4_-_165305086 | 2.27 |
ENST00000507270.1
ENST00000514618.1 ENST00000503008.1 |
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
chr6_-_30654977 | 2.27 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr3_-_52864680 | 2.26 |
ENST00000406595.1
ENST00000485816.1 ENST00000434759.3 ENST00000346281.5 ENST00000266041.4 |
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr19_+_55327923 | 2.24 |
ENST00000391728.4
ENST00000326542.7 ENST00000358178.4 |
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 |
chr2_+_135596180 | 2.23 |
ENST00000283054.4
ENST00000392928.1 |
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr17_-_72619869 | 2.22 |
ENST00000392619.1
ENST00000426295.2 |
CD300E
|
CD300e molecule |
chr4_+_40194609 | 2.22 |
ENST00000508513.1
|
RHOH
|
ras homolog family member H |
chr17_-_72619783 | 2.21 |
ENST00000328630.3
|
CD300E
|
CD300e molecule |
chr10_+_26727125 | 2.19 |
ENST00000376236.4
|
APBB1IP
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
chr7_-_37026108 | 2.19 |
ENST00000396045.3
|
ELMO1
|
engulfment and cell motility 1 |
chr16_-_21663919 | 2.17 |
ENST00000569602.1
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr11_-_104827425 | 2.16 |
ENST00000393150.3
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase |
chr19_+_55235969 | 2.16 |
ENST00000402254.2
ENST00000538269.1 ENST00000541392.1 ENST00000291860.1 ENST00000396284.2 |
KIR3DL1
KIR3DL3
KIR2DL4
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 |
chr14_+_22554680 | 2.14 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
chr4_+_40195262 | 2.12 |
ENST00000503941.1
|
RHOH
|
ras homolog family member H |
chr7_+_139529040 | 2.12 |
ENST00000455353.1
ENST00000458722.1 ENST00000411653.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr7_-_36764004 | 2.12 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chrY_+_22737604 | 2.10 |
ENST00000361365.2
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
chr22_+_23247030 | 2.09 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr8_-_133772870 | 2.08 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
chr1_-_161519579 | 2.08 |
ENST00000426740.1
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr12_-_45269769 | 2.07 |
ENST00000548826.1
|
NELL2
|
NEL-like 2 (chicken) |
chr18_-_67629015 | 2.07 |
ENST00000579496.1
|
CD226
|
CD226 molecule |
chr22_-_37640456 | 2.07 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr1_+_247582097 | 2.06 |
ENST00000391827.2
|
NLRP3
|
NLR family, pyrin domain containing 3 |
chr2_+_90259593 | 2.04 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chrY_+_15016013 | 2.04 |
ENST00000360160.4
ENST00000454054.1 |
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr5_+_40841276 | 2.04 |
ENST00000254691.5
|
CARD6
|
caspase recruitment domain family, member 6 |
chr3_+_38179969 | 2.04 |
ENST00000396334.3
ENST00000417037.2 ENST00000424893.1 ENST00000495303.1 ENST00000443433.2 ENST00000421516.1 |
MYD88
|
myeloid differentiation primary response 88 |
chr2_-_89161064 | 2.02 |
ENST00000390241.2
|
IGKJ2
|
immunoglobulin kappa joining 2 |
chr7_+_139528952 | 2.01 |
ENST00000416849.2
ENST00000436047.2 ENST00000414508.2 ENST00000448866.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr14_-_25078864 | 1.99 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
chr4_-_153601136 | 1.99 |
ENST00000504064.1
ENST00000304385.3 |
TMEM154
|
transmembrane protein 154 |
chr5_-_140013275 | 1.99 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
chr10_+_6625605 | 1.98 |
ENST00000414894.1
ENST00000449648.1 |
PRKCQ-AS1
|
PRKCQ antisense RNA 1 |
chr7_+_74188309 | 1.98 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chr6_-_116866773 | 1.97 |
ENST00000368602.3
|
TRAPPC3L
|
trafficking protein particle complex 3-like |
chr3_-_71777824 | 1.96 |
ENST00000469524.1
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3 |
chr19_-_8567505 | 1.96 |
ENST00000600262.1
|
PRAM1
|
PML-RARA regulated adaptor molecule 1 |
chr21_+_34602680 | 1.96 |
ENST00000447980.1
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2 |
chr1_-_226065330 | 1.96 |
ENST00000436966.1
|
TMEM63A
|
transmembrane protein 63A |
chr5_-_140013224 | 1.95 |
ENST00000498971.2
|
CD14
|
CD14 molecule |
chr8_-_133772794 | 1.92 |
ENST00000519187.1
ENST00000523829.1 ENST00000356838.3 ENST00000377901.4 ENST00000519304.1 |
TMEM71
|
transmembrane protein 71 |
chr14_-_94919103 | 1.91 |
ENST00000334708.3
|
SERPINA11
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
chr2_+_90192768 | 1.91 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr22_-_37640277 | 1.90 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr14_+_102196739 | 1.90 |
ENST00000556973.1
|
RP11-796G6.2
|
Uncharacterized protein |
chr18_-_67624412 | 1.89 |
ENST00000580335.1
|
CD226
|
CD226 molecule |
chr4_-_38806404 | 1.88 |
ENST00000308979.2
ENST00000505940.1 ENST00000515861.1 |
TLR1
|
toll-like receptor 1 |
chr17_-_76356148 | 1.88 |
ENST00000587578.1
ENST00000330871.2 |
SOCS3
|
suppressor of cytokine signaling 3 |
chr16_-_67517716 | 1.88 |
ENST00000290953.2
|
AGRP
|
agouti related protein homolog (mouse) |
chr5_-_140013241 | 1.87 |
ENST00000519715.1
|
CD14
|
CD14 molecule |
chr1_-_167487758 | 1.87 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
chr12_-_45269430 | 1.87 |
ENST00000395487.2
|
NELL2
|
NEL-like 2 (chicken) |
chr5_-_169694286 | 1.87 |
ENST00000521416.1
ENST00000520344.1 |
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chrX_+_135730297 | 1.87 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
chr19_+_55281260 | 1.87 |
ENST00000336077.6
ENST00000291633.7 |
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 |
chr4_+_108815402 | 1.86 |
ENST00000503385.1
|
SGMS2
|
sphingomyelin synthase 2 |
chr22_+_22385332 | 1.86 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr12_+_20963647 | 1.86 |
ENST00000381545.3
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr16_-_21663950 | 1.86 |
ENST00000268389.4
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr3_-_112218378 | 1.85 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
chr14_-_106805716 | 1.84 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
chr22_+_23222886 | 1.84 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr14_+_22538811 | 1.84 |
ENST00000390450.3
|
TRAV22
|
T cell receptor alpha variable 22 |
chr2_-_113594279 | 1.83 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr10_-_72362515 | 1.83 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr6_+_31540056 | 1.82 |
ENST00000418386.2
|
LTA
|
lymphotoxin alpha |
chr14_+_22591276 | 1.82 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
chr12_-_45270077 | 1.81 |
ENST00000551601.1
ENST00000549027.1 ENST00000452445.2 |
NELL2
|
NEL-like 2 (chicken) |
chr16_+_50730910 | 1.81 |
ENST00000300589.2
|
NOD2
|
nucleotide-binding oligomerization domain containing 2 |
chr22_+_25003626 | 1.80 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chr7_+_139529085 | 1.80 |
ENST00000539806.1
|
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr2_+_85804614 | 1.79 |
ENST00000263864.5
ENST00000409760.1 |
VAMP8
|
vesicle-associated membrane protein 8 |
chr12_-_45269251 | 1.79 |
ENST00000553120.1
|
NELL2
|
NEL-like 2 (chicken) |
chr6_-_32151999 | 1.77 |
ENST00000375069.3
ENST00000538695.1 ENST00000438221.2 ENST00000375065.5 ENST00000450110.1 ENST00000375067.3 ENST00000375056.2 |
AGER
|
advanced glycosylation end product-specific receptor |
chr19_-_8567478 | 1.77 |
ENST00000255612.3
|
PRAM1
|
PML-RARA regulated adaptor molecule 1 |
chr12_+_56324933 | 1.77 |
ENST00000549629.1
ENST00000555218.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr22_-_24096562 | 1.76 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr17_-_26697304 | 1.74 |
ENST00000536498.1
|
VTN
|
vitronectin |
chr22_+_23010756 | 1.74 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr22_+_23241661 | 1.73 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr11_+_58695174 | 1.73 |
ENST00000317391.4
|
GLYATL1
|
glycine-N-acyltransferase-like 1 |
chr2_-_207583120 | 1.73 |
ENST00000452335.2
|
DYTN
|
dystrotelin |
chr22_-_50523807 | 1.73 |
ENST00000442311.1
ENST00000538737.1 |
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
chr5_-_179499108 | 1.72 |
ENST00000521389.1
|
RNF130
|
ring finger protein 130 |
chr22_-_50523843 | 1.70 |
ENST00000535444.1
ENST00000431262.2 |
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
chr4_-_185820602 | 1.70 |
ENST00000515864.1
ENST00000507183.1 |
RP11-701P16.4
|
long intergenic non-protein coding RNA 1093 |
chr10_-_6019552 | 1.70 |
ENST00000379977.3
ENST00000397251.3 ENST00000397248.2 |
IL15RA
|
interleukin 15 receptor, alpha |
chr19_+_51728316 | 1.69 |
ENST00000436584.2
ENST00000421133.2 ENST00000391796.3 ENST00000262262.4 |
CD33
|
CD33 molecule |
chr7_+_117120017 | 1.69 |
ENST00000003084.6
ENST00000454343.1 |
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
chr2_+_135596106 | 1.68 |
ENST00000356140.5
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr1_-_161519682 | 1.68 |
ENST00000367969.3
ENST00000443193.1 |
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr11_+_128563652 | 1.67 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr7_-_29186008 | 1.67 |
ENST00000396276.3
ENST00000265394.5 |
CPVL
|
carboxypeptidase, vitellogenic-like |
chr19_-_7764960 | 1.67 |
ENST00000593418.1
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr14_+_21249200 | 1.67 |
ENST00000304677.2
|
RNASE6
|
ribonuclease, RNase A family, k6 |
chr19_+_55128576 | 1.66 |
ENST00000396331.1
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr5_-_147211190 | 1.66 |
ENST00000510027.2
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
chr14_+_22675388 | 1.65 |
ENST00000390461.2
|
TRAV34
|
T cell receptor alpha variable 34 |
chr12_-_103352144 | 1.65 |
ENST00000551337.1
|
PAH
|
phenylalanine hydroxylase |
chr11_+_121461097 | 1.64 |
ENST00000527934.1
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr16_+_85932760 | 1.64 |
ENST00000565552.1
|
IRF8
|
interferon regulatory factor 8 |
chr9_-_123812542 | 1.64 |
ENST00000223642.1
|
C5
|
complement component 5 |
chr7_-_38315919 | 1.64 |
ENST00000390339.1
|
TRGJP1
|
T cell receptor gamma joining P1 |
chr5_-_13944652 | 1.64 |
ENST00000265104.4
|
DNAH5
|
dynein, axonemal, heavy chain 5 |
chr22_-_50523688 | 1.64 |
ENST00000450140.2
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
2.0 | 6.0 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
1.6 | 6.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
1.6 | 9.5 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
1.6 | 4.7 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
1.5 | 3.0 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
1.5 | 5.8 | GO:0071725 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
1.2 | 3.5 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
1.1 | 1.1 | GO:2001179 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
1.0 | 3.8 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 13.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.9 | 1.8 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.9 | 5.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.8 | 5.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.8 | 4.8 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.8 | 2.3 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.8 | 2.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.8 | 5.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.8 | 8.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 3.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 3.6 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.7 | 1.4 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.7 | 2.9 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.7 | 2.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.7 | 3.4 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.7 | 2.0 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.7 | 8.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 1.9 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.6 | 5.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.6 | 1.9 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
0.6 | 2.6 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.6 | 3.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.6 | 3.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.6 | 1.8 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.6 | 3.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 1.6 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.5 | 3.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.5 | 3.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.5 | 1.6 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.5 | 1.6 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.5 | 5.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 2.0 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 2.0 | GO:0052360 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.5 | 1.4 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
0.5 | 8.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 1.9 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.5 | 2.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.4 | 2.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 2.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.4 | 2.6 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.4 | 1.7 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.4 | 1.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.4 | 4.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 1.2 | GO:1903413 | cellular response to bile acid(GO:1903413) response to iron ion starvation(GO:1990641) |
0.4 | 1.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.4 | 1.5 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.4 | 5.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 1.1 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.4 | 1.4 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.3 | 1.0 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.3 | 2.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 2.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.3 | 1.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 1.3 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.3 | 2.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.3 | 2.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.9 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 6.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 0.9 | GO:0070839 | spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.3 | 3.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 0.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 3.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 0.9 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
0.3 | 2.9 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.3 | 5.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 4.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 1.1 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.3 | 0.6 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.3 | 1.9 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
0.3 | 1.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 4.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 1.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.3 | 1.9 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 0.8 | GO:0045556 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.3 | 0.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.3 | 2.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.3 | 2.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 1.0 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.3 | 2.1 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.3 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 9.8 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 0.5 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.2 | 2.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.0 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.2 | 1.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 1.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 2.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 3.7 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 1.6 | GO:0072679 | thymocyte migration(GO:0072679) |
0.2 | 0.6 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.6 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.2 | 0.8 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.2 | 0.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 4.4 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.2 | 0.6 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.2 | 0.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.2 | 6.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 1.7 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.2 | 1.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 1.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 0.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 0.6 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.2 | 3.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 0.7 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.2 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.9 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.2 | 1.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.2 | 0.3 | GO:1900005 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
0.2 | 1.0 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 2.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.5 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 1.5 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.2 | 3.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.3 | GO:0070426 | nitric oxide production involved in inflammatory response(GO:0002537) positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
0.2 | 1.0 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.9 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.2 | 1.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 2.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 2.7 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 1.7 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 1.4 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.2 | 0.6 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.5 | GO:0038163 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) |
0.2 | 2.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.1 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.1 | 0.6 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.1 | 1.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 4.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 7.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.6 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.1 | 0.6 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 | 1.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 8.1 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.4 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.1 | 0.8 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.8 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 1.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 2.8 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 33.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 1.6 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 1.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 0.4 | GO:0071400 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) cellular response to oleic acid(GO:0071400) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.1 | 1.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.7 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 1.8 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 3.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 1.3 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 11.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.7 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 2.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 1.9 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 1.6 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 1.0 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.1 | 1.3 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.1 | 0.9 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 7.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 1.0 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.9 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.6 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.1 | 2.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.1 | 0.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.9 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 2.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 1.8 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.1 | 0.6 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.4 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.9 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 1.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.8 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 1.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 1.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 2.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 1.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 2.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.4 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 10.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.6 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 4.4 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.5 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 1.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 3.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.9 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 0.3 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.1 | 1.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 3.6 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 1.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.5 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.1 | 0.3 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 0.6 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.1 | 0.7 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.1 | 0.3 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 2.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.3 | GO:0090425 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.9 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.3 | GO:0039521 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.1 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 2.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.7 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 1.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.2 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.1 | 0.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.6 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 1.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.8 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 1.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.9 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 1.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.1 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.1 | 0.7 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 1.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 1.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 1.1 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.1 | 0.3 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.2 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.1 | 0.2 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.1 | 2.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 11.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.5 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 5.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.5 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.1 | 0.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 1.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 1.2 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 1.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.3 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
0.1 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.3 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.5 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 3.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.8 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 1.3 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.4 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.1 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.1 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 1.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 4.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 1.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 2.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.3 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.7 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 2.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.7 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 | 0.9 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.3 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.0 | 0.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.5 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.0 | 2.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 2.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 1.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.3 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 1.6 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.7 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.2 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.0 | 2.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.5 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.0 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 1.0 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 2.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 1.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 1.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.4 | GO:0021915 | neural tube development(GO:0021915) |
0.0 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 1.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 1.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.7 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.3 | GO:0006569 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.4 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.1 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 1.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.9 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 1.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.2 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 1.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 1.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.3 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.2 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.0 | 6.9 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.2 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 14.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 1.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 1.4 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 1.9 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 1.0 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.2 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.0 | 0.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 1.3 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 1.0 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.0 | 0.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.4 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.1 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 1.0 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 2.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 2.9 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.0 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 1.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.5 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.5 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 1.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
1.0 | 9.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.0 | 13.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 6.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 3.3 | GO:0036398 | TCR signalosome(GO:0036398) |
0.6 | 2.3 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.6 | 2.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.5 | 1.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.5 | 2.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 1.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.4 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 2.0 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.4 | 2.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 7.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 3.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 1.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 2.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 5.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.3 | 1.0 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 1.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 2.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 1.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.2 | 1.0 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.2 | 1.0 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.2 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.7 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.2 | 16.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.6 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 2.5 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.2 | 5.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 4.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 1.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 0.8 | GO:0070701 | mucus layer(GO:0070701) |
0.2 | 0.5 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.1 | 4.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 5.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 2.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.9 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.1 | 0.6 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 1.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.6 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 0.9 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 20.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 0.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 2.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 14.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 3.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 1.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.4 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 1.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.6 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 6.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.4 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 2.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.1 | 28.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.3 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.1 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 4.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 3.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 5.3 | GO:0005901 | caveola(GO:0005901) |
0.1 | 4.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.0 | 0.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 1.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 3.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 4.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 2.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 5.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 1.5 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 8.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 2.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 3.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 1.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 1.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 2.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 1.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 2.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 2.9 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 5.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 8.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.0 | 1.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 1.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 1.0 | GO:0032991 | macromolecular complex(GO:0032991) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 2.2 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.6 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 2.4 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 2.9 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 7.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 3.8 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 1.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 22.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 9.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.6 | 6.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
1.6 | 4.7 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
1.5 | 5.9 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
1.4 | 5.5 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
1.2 | 6.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
1.2 | 6.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.2 | 3.5 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
1.1 | 1.1 | GO:0001855 | complement component C4b binding(GO:0001855) |
1.1 | 3.4 | GO:0005174 | CD40 receptor binding(GO:0005174) |
1.0 | 6.1 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
1.0 | 2.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.0 | 5.8 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.9 | 3.6 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.8 | 3.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.8 | 3.8 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.7 | 3.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.7 | 3.0 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
0.7 | 2.9 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.7 | 2.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.7 | 13.0 | GO:0019864 | IgG binding(GO:0019864) |
0.6 | 1.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 1.6 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.5 | 3.9 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.5 | 1.9 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.4 | 5.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 2.6 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.4 | 2.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.4 | 6.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.4 | 1.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.4 | 2.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 1.1 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
0.4 | 4.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.4 | 1.4 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.3 | 6.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 1.0 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
0.3 | 1.0 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.3 | 2.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 1.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.3 | 2.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.3 | 2.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.3 | 1.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.3 | 0.9 | GO:0097689 | iron channel activity(GO:0097689) |
0.3 | 0.9 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.3 | 4.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.3 | 2.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 2.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 2.8 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.3 | 1.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 6.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 3.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 0.8 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.3 | 0.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 1.9 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 1.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 1.0 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 0.8 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.3 | 1.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 7.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 1.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 0.7 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.2 | 7.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 3.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 1.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.6 | GO:0046979 | TAP2 binding(GO:0046979) |
0.2 | 5.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 2.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 3.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 1.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 3.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 4.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 0.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 3.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 2.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.3 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.2 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 1.6 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.5 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.2 | 1.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.2 | 0.5 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.2 | 0.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 2.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.0 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.2 | 1.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 0.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.3 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.2 | 37.0 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 1.7 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 3.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.9 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.6 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.6 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 2.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 3.8 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 3.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.7 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.9 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 0.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 2.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.3 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.6 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0052835 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.1 | 3.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 1.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 2.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.3 | GO:0004630 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.5 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.1 | 0.6 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 2.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.4 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.1 | 1.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.3 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.1 | 10.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 1.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 2.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 1.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 2.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
0.1 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.0 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 4.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 2.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.5 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 1.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.7 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.1 | 3.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 1.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 6.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 2.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 2.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 9.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 3.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.1 | 0.3 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
0.1 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 1.0 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 3.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.1 | 1.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 3.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 1.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 5.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 1.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 4.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 1.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 2.2 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.0 | 7.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 2.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 2.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.0 | 1.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 6.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 1.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 1.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 2.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 10.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.3 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.7 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 1.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.0 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 3.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 1.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 1.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 1.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 1.1 | GO:0070035 | ATP-dependent DNA helicase activity(GO:0004003) ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 1.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 1.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.1 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 3.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 1.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 2.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.6 | GO:0008233 | peptidase activity(GO:0008233) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 1.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 22.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 14.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 11.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 9.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 1.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 4.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 8.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 10.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 7.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 4.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 14.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 4.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 5.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 4.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 5.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 5.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 1.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 2.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 5.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 2.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 6.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 2.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 3.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 4.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | NABA COLLAGENS | Genes encoding collagen proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 12.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 8.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 51.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 6.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 9.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 4.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 7.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 7.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 2.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 3.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 9.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 4.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 7.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 7.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 2.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 7.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 6.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 6.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 8.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 5.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 8.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 2.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 3.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 4.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 6.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 2.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 4.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 4.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.6 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 2.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 3.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 2.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 2.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 4.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 2.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 2.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 1.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 1.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 2.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 1.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.9 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 1.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.8 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 3.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 5.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |